Shire Expects Intuniv Launch In Mid-’09, As Firm’s ADHD Share Tops 30%
Executive Summary
Shire plans to launch its nonstimulant ADHD candidate Intuniv in the second half of 2009, though new studies may be required to gain FDA approvalRegister for our free email digests: